Impact of GLP-1 Receptor Agonists on Patients With IPMN
Impact of GLP-1 Receptor Agonists on Patients With IPMN
Not yet recruiting · NCT07014709 · Registry updated 2025-06-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Impact of GLP-1 Receptor Agonists on Patients With IPMN | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Ductal, Lobular, and Medullary, Pancreatic Intraductal Neoplasms, Pancreatic Intraductal Papillary Mucinous Neoplasm, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic intraductal papillary-mucinous neoplasm, pancreatic neoplasm | Not yet recruiting | Not stated | 2025-06-11 | NCT07014709 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hôpital Fribourgeois | 12 |
| Insel Gruppe AG, University Hospital Bern | 224 |
| University Hospital, Geneva | 108 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| HFR Hopital fribourgeois | Villars-sur-Glâne | Switzerland | 1 |